DK1883695T3 - Probiotisk bifidobakterieart - Google Patents

Probiotisk bifidobakterieart

Info

Publication number
DK1883695T3
DK1883695T3 DK06725493T DK06725493T DK1883695T3 DK 1883695 T3 DK1883695 T3 DK 1883695T3 DK 06725493 T DK06725493 T DK 06725493T DK 06725493 T DK06725493 T DK 06725493T DK 1883695 T3 DK1883695 T3 DK 1883695T3
Authority
DK
Denmark
Prior art keywords
bifidobacterium
probiotic bifidobacteria
bifidobacteria species
cncm
probiotic
Prior art date
Application number
DK06725493T
Other languages
Danish (da)
English (en)
Inventor
Veronique Delcenserie
Georges Daube
Francoise Gavini
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Application granted granted Critical
Publication of DK1883695T3 publication Critical patent/DK1883695T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06725493T 2005-05-16 2006-03-31 Probiotisk bifidobakterieart DK1883695T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05104071 2005-05-16
PCT/EP2006/061247 WO2006122850A1 (en) 2005-05-16 2006-03-31 Probiotic bifidobacterial species

Publications (1)

Publication Number Publication Date
DK1883695T3 true DK1883695T3 (da) 2009-07-20

Family

ID=34982549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06725493T DK1883695T3 (da) 2005-05-16 2006-03-31 Probiotisk bifidobakterieart

Country Status (9)

Country Link
US (1) US7959912B2 (cg-RX-API-DMAC7.html)
EP (1) EP1883695B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008539776A (cg-RX-API-DMAC7.html)
AT (1) ATE432337T1 (cg-RX-API-DMAC7.html)
CA (1) CA2602693A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006006997D1 (cg-RX-API-DMAC7.html)
DK (1) DK1883695T3 (cg-RX-API-DMAC7.html)
ES (1) ES2325887T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006122850A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997907A1 (en) 2007-06-01 2008-12-03 Friesland Brands B.V. Bifidobacteria
JP5327984B2 (ja) * 2007-10-20 2013-10-30 ユニベルシテ・ド・リエージュ ビフィズス菌の種
US9649380B2 (en) * 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
DK2338350T3 (en) * 2009-12-24 2016-06-06 Csk Food Enrichment Bv Fermented milk product
RU2451734C2 (ru) * 2010-05-14 2012-05-27 Татьяна Александровна Левченко ШТАММ Bifidobacterium adolescentis 79-82, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
RU2451735C2 (ru) * 2010-05-28 2012-05-27 Татьяна Александровна Левченко ШТАММ Bifidobacterium adolescentis 79-84, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
WO2011148220A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving transepithelial resistance
US9980501B2 (en) 2014-12-26 2018-05-29 Salah Mohammed Aleid Method of making probiotic dairy products with date syrup additive
CN107653306B (zh) * 2017-11-13 2020-05-08 江南大学 一种基于高通量测序的双歧杆菌快速检测方法及应用
BE1028802B1 (fr) 2020-11-16 2022-06-14 Le Centre Wallon De Rech Agronomiques Développement d'une composition symbiotique comme un additif d'alimentation pour les porcelets ou les truies gestantes pour moduler le microbiote intestinal des porcelets au temps du sevrage
IT202200022401A1 (it) * 2022-10-31 2024-05-01 Probionova Sa Ceppi di batteri per il trattamento di disturbi urologici, loro composizioni e usi relativi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium

Also Published As

Publication number Publication date
EP1883695B1 (en) 2009-05-27
DE602006006997D1 (de) 2009-07-09
EP1883695A1 (en) 2008-02-06
ATE432337T1 (de) 2009-06-15
CA2602693A1 (en) 2006-11-23
ES2325887T3 (es) 2009-09-23
JP2008539776A (ja) 2008-11-20
WO2006122850A1 (en) 2006-11-23
US7959912B2 (en) 2011-06-14
US20080274085A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
Endo et al. Bifidobacterium reuteri sp. nov., Bifidobacterium callitrichos sp. nov., Bifidobacterium saguini sp. nov., Bifidobacterium stellenboschense sp. nov. and Bifidobacterium biavatii sp. nov. isolated from faeces of common marmoset (Callithrix jacchus) and red-handed tamarin (Saguinus midas)
ES2524432T3 (es) Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas
EP1473370A3 (en) Genus, group, species and/or strain specific 16S rDNA Sequences
NZ737752A (en) Compositions comprising bacterial strains
MX349705B (es) Bifidobacterium longum.
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
DK1883695T3 (da) Probiotisk bifidobakterieart
WO2019175783A8 (en) Compositions comprising bacterial strains and use thereof in controlling pathogenic microorganisms
EP2512266A4 (en) PROBIOTIC COMPOSITIONS, METHOD AND DEVICE FOR THEIR ADMINISTRATION
EA201101019A1 (ru) Новый штамм pasteuria
Demarta et al. Aeromonas tecta sp. nov., isolated from clinical and environmental sources
UA93542C2 (ru) Штамм молочнокислых бактерий streptococcus thermophilus, который обеспечивает улучшенную текстуру ферментированных продуктов
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
PL2040560T3 (pl) Granulki cysteinowe i ich zastosowanie jako stymulatora wzrostu Bifidobacterium animalis lactis
Khianngam et al. Flavobacterium arsenitoxidans sp. nov., an arsenite-oxidizing bacterium from Thai soil
NZ602202A (en) Treatment of plants against oomycete infection
MX2016003676A (es) Bacteria aislada del genero streptomyces.
MX2007004880A (es) Cepas de streptococcus thermophilus deficientes en aminopterina, con post-acidificacion reducida.
WO2023137381A3 (en) Bifidobacterium infantis formulations
SG11202000113QA (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof
WO2008132984A1 (ja) アスタキサンチン産生細菌、細菌培養物、アスタキサンチン含有組成物およびアスタキサンチンの製造方法
WO2008129934A1 (ja) アスタキサンチン産生細菌、細菌培養物、アスタキサンチン含有組成物およびアスタキサンチンの製造方法
JP2008220172A5 (cg-RX-API-DMAC7.html)
PH12016500535A1 (en) Agricultural uses of a novel bacterium of the genus streptomyces